Month: January 2023

New Phase I clinical trial protocol submitted to FDA to treat subjects with xerostomia after XRT for Head and Neck Cancer using “fresh” interferon-γ activated MSCs at UW Health

Posted on January 10, 2023

A new clinical trial protocol to be covered under an investigator-sponsored IND held by UW Program for Advanced for Advanced Cell Therapy was submitted to the FDA this week. Randall Kimple MD, PhD, UW Associate …